Arnold School of Public Health Department of Epidemiology and Biostatistics University of South Carolina Columbia SC USA

Biomedical Center Faculty of Medicine and Biomedical Center in Pilsen Charles University Prague 30605 Pilsen Czech Republic

Center for Primary Health Care Research Lund University Malmo Sweden

Centre for Bone and Arthritis Research Department of Internal Medicine and Clinical Nutrition Institute of Medicine Sahlgrenska Academy University of Gothenburg Gothenburg Sweden

Clinical Pharmacology Department of Integrative Medical Biology Umea University Umea Sweden

Department of Biomedicine University of Basel Basel Switzerland

Department of Hematooncology University Hospital Ostrava and Faculty of Medicine University of Ostrava Ostrava Czech Republic

Department of Internal Medicine 3 University of Ulm Ulm Germany

Department of Internal Medicine 5 University of Heidelberg Heidelberg Germany

Department of Lymphoma Myeloma University of Texas MD Anderson Cancer Center Houston TX USA

Department of Public Health and Clinical Medicine Umea University Umea Sweden

Department of Radiation Sciences Oncology Umeå University Umeå Sweden

Division of Cancer Epidemiology German Cancer Research Center Im Neuenheimer Feld 580 D 69120 Heidelberg Germany

Division of Clinical Genetics Department of Laboratory Medicine Lund University Lund Sweden

Division of Computational Genomics Mayo Clinic Rochester MN USA

Division of Epidemiology Department of Quantitative Health Sciences Mayo Clinic Rochester MN USA

Division of Genetics and Epidemiology The Institute of Cancer Research London UK

Division of Hematology Mayo Clinic Rochester Mayo Clinic Rochester MN USA

Division of Pediatric Neurooncology German Cancer Research Center Heidelberg Germany

Faculty of Medicine and Biomedical Center in Pilsen Charles University Prague 30605 Pilsen Czech Republic

GeneWerk GmbH Im Neuenheimer Feld 582 6910 Heidelberg Germany

Hopp Children's Cancer Center Heidelberg Germany

Institute for Medical Informatics Biometry and Epidemiology University Hospital Essen University of Duisburg Essen Duisburg Germany

Institute of Biology and Medical Genetics 1st Medical Faculty Charles University Albertov 4 128 00 Prague Czech Republic

Institute of Experimental Medicine Academy of Sciences of the Czech Republic Videnska 1083 142 00 Prague Czech Republic

Institute of Human Genetics University of Bonn Bonn Germany

National Centre of Tumor Diseases Heidelberg Germany

See more in PubMed

Kyle RA, Therneau TM, Rajkumar SV, Larson DR, Plevak MF, Offord JR, et al. Prevalence of monoclonal gammopathy of undetermined significance. N Engl J Med. 2006;354:1362–9. doi: 10.1056/NEJMoa054494. PubMed DOI

Greenberg AJ, Rajkumar SV, Vachon CM. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics. Blood. 2012;119:5359–66. doi: 10.1182/blood-2011-11-387324. PubMed DOI PMC

Went M, Sud A, Forsti A, Halvarsson BM, Weinhold N, Kimber S, et al. Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma. Nat Commun. 2018;9:3707. doi: 10.1038/s41467-018-04989-w. PubMed DOI PMC

Duran-Lozano L, Thorleifsson G, Lopez de Lapuente Portilla A, Niroula A, Went M, Thodberg M, et al. Germline variants at SOHLH2 influence multiple myeloma risk. Blood Cancer J. 2021;11:76. doi: 10.1038/s41408-021-00468-6. PubMed DOI PMC

Clay-Gilmour AI, Hildebrandt MAT, Brown EE, Hofmann JN, Spinelli JJ, Giles GG, et al. Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance. Blood Adv. 2020;4:2789–97. doi: 10.1182/bloodadvances.2020001435. PubMed DOI PMC

Thomsen H, Chattopadhyay S, Weinhold N, Vodicka P, Vodickova L, Hoffmann P, et al. Genome-wide association study of monoclonal gammopathy of unknown significance (MGUS): comparison with multiple myeloma. Leukemia. 2019;33:1817–21. doi: 10.1038/s41375-019-0396-x. PubMed DOI

Kheradpour P, Kellis M. Systematic discovery and characterization of regulatory motifs in ENCODE TF binding experiments. Nucleic Acids Res. 2014;42:2976–87. doi: 10.1093/nar/gkt1249. PubMed DOI PMC

Ambrosini G, Vorontsov I, Penzar D, Groux R, Fornes O, Nikolaeva DD, et al. Insights gained from a comprehensive all-against-all transcription factor binding motif benchmarking study. Genome Biol. 2020;21:114. doi: 10.1186/s13059-020-01996-3. PubMed DOI PMC

Chubb D, Weinhold N, Broderick P, Chen B, Johnson DC, Forsti A, et al. Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. Nat Genet. 2013;45:1221–5. doi: 10.1038/ng.2733. PubMed DOI PMC

Chattopadhyay S, Thomsen H, Weinhold N, Meziane I, Huhn S, da Silva Filho MI, et al. Eight novel loci implicate shared genetic etiology in multiple myeloma, AL amyloidosis, and monoclonal gammopathy of unknown significance. Leukemia. 2020;34:1187–91. doi: 10.1038/s41375-019-0619-1. PubMed DOI

da Silva Filho MI, Försti A, Weinhold N, Meziane I, Campo C, Huhn S, et al. Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison to myeloma. Leukemia. 2017;31:1735–42. doi: 10.1038/leu.2016.387. PubMed DOI

Oberbeck N, Pham VC, Webster JD, Reja R, Huang CS, Zhang Y, et al. The RIPK4-IRF6 signalling axis safeguards epidermal differentiation and barrier function. Nature. 2019;574:249–53. doi: 10.1038/s41586-019-1615-3. PubMed DOI

Li N, Johnson DC, Weinhold N, Studd JB, Orlando G, Mirabella F, et al. Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expression. Nat Commun. 2016;7:13656. doi: 10.1038/ncomms13656. PubMed DOI PMC

Weinhold N, Meissner T, Johnson DC, Seckinger A, Moreaux J, Forsti A, et al. The 7p15.3 (rs4487645) association for multiple myeloma shows strong allele-specific regulation of the MYC-interacting gene CDCA7L in malignant plasma cells. Haematologica. 2015;100:e110–3. doi: 10.3324/haematol.2014.118786. PubMed DOI PMC

McMaster ML, Berndt SI, Zhang J, Slager SL, Li SA, Vajdic CM, et al. Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenstrom macroglobulinemia. Nat Commun. 2018;9:4182. doi: 10.1038/s41467-018-06541-2. PubMed DOI PMC

Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance